References
- Ancuceanu, R., Tamba, B., Stoicescu, C. S., & Dinu, M. (2019). Use of QSAR global models and molecular docking for developing new inhibitors of C-src tyrosine kinase. International Journal of Molecular Sciences, 21(1), 19. https://doi.org/https://doi.org/10.3390/ijms21010019
- Ascher, D. B., Wielens, J., Nero, T. L., Doughty, L., Morton, C. J., & Parker, M. W. (2014). Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA. Scientific reports, 4(1), 4765. https://doi.org/https://doi.org/10.1038/srep04765
- Bartenschlager, R., Baumert, T. F., Bukh, J., Houghton, M., Lemon, S. M., Lindenbach, B. D., Lohmann, V., Moradpour, D., Pietschmann, T., Rice, C. M., Thimme, R., & Wakita, T. (2018). Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies. Virus Research, 248, 53–62. https://doi.org/https://doi.org/10.1016/j.virusres.2018.02.016
- Baumert, T. F., & Hoshida, Y. (2019). Addressing the challenges of hepatitis C cure and persistent risk of hepatocellular carcinoma. Viruses, 11(5), 441. https://doi.org/https://doi.org/10.3390/v11050441
- Berman, K., & Kwo, P. Y. (2009). Boceprevir, an NS3 protease inhibitor of HCV. Clinics in Liver Disease, 13(3), 429–439. https://doi.org/https://doi.org/10.1016/j.cld.2009.05.008
- Bryson, P. D., Cho, N.-J., Einav, S., Lee, C., Tai, V., Bechtel, J., Sivaraja, M., Roberts, C., Schmitz, U., & Glenn, J. S. (2010). A small molecule inhibits HCV replication and alters NS4B's subcellular distribution. Antiviral Research, 87(1), 1–8. https://doi.org/https://doi.org/10.1016/j.antiviral.2010.03.013
- Chen, G., Ren, H., Turpoff, A., Arefolov, A., Wilde, R., Takasugi, J., Khan, A., Almstead, N., Gu, Z., Komatsu, T., Freund, C., Breslin, J., Colacino, J., Hedrick, J., Weetall, M., & Karp, G. M. (2013). Discovery of N-(4'-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication. Bioorganic & Medicinal Chemistry Letters, 23(13), 3942–3946. https://doi.org/https://doi.org/10.1016/j.bmcl.2013.04.050
- Chen, G., Ren, H., Zhang, N., Lennox, W., Turpoff, A., Paget, S., Li, C., Almstead, N., Njoroge, F. G., Gu, Z., Graci, J., Jung, S. P., Colacino, J., Lahser, F., Zhao, X., Weetall, M., Nomeir, A., & Karp, G. M. (2015). 6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4B. Bioorganic & Medicinal Chemistry Letters, 25(4), 781–786. https://doi.org/https://doi.org/10.1016/j.bmcl.2014.12.093
- Chirico, N., & Gramatica, P. (2011). Real external predictivity of QSAR models: How to evaluate it? Comparison of different validation criteria and proposal of using the concordance correlation coefficient. Journal of Chemical Information and Modeling, 51(9), 2320–2335. https://doi.org/https://doi.org/10.1021/ci200211n
- Chirico, N., & Gramatica, P. (2012). Real external predictivity of QSAR models. Part 2. New intercomparable thresholds for different validation criteria and the need for scatter plot inspection. Journal of Chemical Information and Modeling, 52(8), 2044–2058. https://doi.org/https://doi.org/10.1021/ci300084j
- Cho, N.-J., Dvory-Sobol, H., Lee, C., Cho, S.-J., Bryson, P., Masek, M., Elazar, M., Frank, C. W., & Glenn, J. S. (2010). Identification of a class of HCV inhibitors directed against the nonstructural protein NS4B. Science Translational Medicine, 2(15), 15ra6. https://doi.org/https://doi.org/10.1126/scitranslmed.3000331
- Chunduru, S. K., Benatatos, C. A., Theodore, J., Nitz, Bailey, T. R. (n.d.). US 2007/0269420 A1 - Compounds, Compositions And Methods For Treatment And Prophylaxis Of Hepatitis C Viral Infections And Associated Diseases – The Lens – Free & Open Patent and Scholarly Search. Retrieved November 9, 2019, from https://www.lens.org/lens/patent/192-743-375-133-003/fulltext
- Consonni, V., & Todeschini, R. (2012). Multivariate analysis of molecular descriptors. In Statistical Modelling of molecular descriptors in QSAR/QSPR (pp. 111–147). Wiley-VCH Verlag GmbH & Co. KGaA. https://doi.org/https://doi.org/10.1002/9783527645121.ch4
- Cox, A. L. (2015). MEDICINE. Global control of hepatitis C virus. Science (New York, N.Y.), 349(6250), 790–791. https://doi.org/https://doi.org/10.1126/science.aad1302
- Cruz, J. N., Costa, J. F. S., Khayat, A. S., Kuca, K., Barros, C. A. L., & Neto, A. M. J. C. (2019). Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13. Journal of Biomolecular Structure & Dynamics, 37(6), 1616–1627. https://doi.org/https://doi.org/10.1080/07391102.2018.1462734
- da Costa, K. S., Galúcio, J. M., da Costa, C. H. S., Santana, A. R., Dos Santos Carvalho, V., do Nascimento, L. D., Lima E Lima, A. H., Neves Cruz, J., Alves, C. N., & Lameira, J. (2019). Exploring the potentiality of natural products from essential oils as inhibitors of odorant-binding proteins: A structure- and ligand-based virtual screening approach to find novel mosquito repellents. ACS Omega, 4(27), 22475–22486. https://doi.org/https://doi.org/10.1021/acsomega.9b03157
- Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 42717. https://doi.org/https://doi.org/10.1038/srep42717
- de Campos, L. J., & de Melo, E. B. (2017). A QSAR study of integrase strand transfer inhibitors based on a large set of pyrimidine, pyrimidone, and pyridopyrazine carboxamide derivatives. Journal of Molecular Structure, 1141, 252–260. https://doi.org/https://doi.org/10.1016/j.molstruc.2017.03.103
- De Clercq, E. (2014). Current race in the development of DAAs (direct-acting antivirals) against HCV. Biochemical Pharmacology 89(4), 441–452. June 15). https://doi.org/https://doi.org/10.1016/j.bcp.2014.04.005
- Devinyak, O., Havrylyuk, D., & Lesyk, R. (2014). 3D-MoRSE descriptors explained. Journal of Molecular Graphics and Modelling, 54, 194–203. https://doi.org/https://doi.org/10.1016/j.jmgm.2014.10.006
- Dufner-Beattie, J., O'Guin, A., O'Guin, S., Briley, A., Wang, B., Balsarotti, J., Roth, R., Starkey, G., Slomczynska, U., Noueiry, A., Olivo, P. D., & Rice, C. M. (2014). Identification of AP80978, a novel small-molecule inhibitor of hepatitis C virus replication that targets NS4B. Antimicrobial Agents and Chemotherapy, 58(6), 3399–3410. https://doi.org/https://doi.org/10.1128/AAC.00113-14
- Dvory-Sobol, H., Pang, P. S., & Glenn, J. S. (2010). The future of HCV therapy: NS4B as an antiviral target. Viruses, 2(11), 2481–2492. https://doi.org/https://doi.org/10.3390/v2112481
- El-Hasab, M. A. E. M., El-Bastawissy, E. E., & El-Moselhy, T. F. (2018). Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein-ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation. Journal of Biomolecular Structure & Dynamics, 36(7), 1713–1727. https://doi.org/https://doi.org/10.1080/07391102.2017.1332689
- Eriksson, L., Jaworska, J., Worth, A. P., Cronin, M. T. D., McDowell, R. M., & Gramatica, P. (2003). Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environmental Health Perspectives, 111(10), 1361–1375. https://doi.org/https://doi.org/10.1289/ehp.5758
- Fechner, U., Franke, L., Renner, S., Schneider, P., & Schneider, G. (2003). Comparison of correlation vector methods for ligand-based similarity searching. Journal of Computer-Aided Molecular Design, 17(10), 687–698. https://doi.org/https://doi.org/10.1023/B:JCAM.0000017375.61558.ad
- Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., … Fox, D. J. (2009). Gaussian 09, Wallingford CT. Retrieved from http://gaussian.com/
- Ganta, N. M., Gedda, G., Rathnakar, B., Satyanarayana, M., Yamajala, B., Ahsan, M. J., Jadav, S. S., & Balaraju, T. (2019). A review on HCV inhibitors: Significance of non-structural polyproteins. European Journal of Medicinal Chemistry, 164, 576–601. https://doi.org/https://doi.org/10.1016/j.ejmech.2018.12.045
- Golbraikh, A., & Tropsha, A. (2002). Beware of q2. !Journal of Molecular Graphics & Modelling, 20(4), 269–276. https://doi.org/https://doi.org/10.1016/S1093-3263(01)00123-1
- Gouttenoire, J., Penin, F., & Moradpour, D. (2010). Hepatitis C virus nonstructural protein 4B: A journey into unexplored territory. Reviews in Medical Virology, 20(2), 117–129. https://doi.org/https://doi.org/10.1002/rmv.640
- Gramatica, P. (2007). Principles of QSAR models validation: Internal and external. QSAR & Combinatorial Science, 26(5), 694–701. https://doi.org/https://doi.org/10.1002/qsar.200610151
- Gramatica, P., Cassani, S., & Chirico, N. (2014). QSARINS-chem: Insubria datasets and new QSAR/QSPR models for environmental pollutants in QSARINS. Journal of Computational Chemistry, 35(13), 1036–1044. https://doi.org/https://doi.org/10.1002/jcc.23576
- Gramatica, P., Chirico, N., Papa, E., Cassani, S., & Kovarich, S. (2013). QSARINS: A new software for the development, analysis, and validation of QSAR MLR models. Journal of Computational Chemistry, 34(24), 2121–2132. https://doi.org/https://doi.org/10.1002/jcc.23361
- Hall, L. H. (2012). Development of structure information from molecular topology for modeling chemical and biological properties: A tribute to the creativity of Lemont Burwell Kier on his 80th birthday. Current Computer-Aided Drug Design, 8(2), 93–106. https://doi.org/https://doi.org/10.2174/157340912800492393
- Hdoufane, I., Stoycheva, J., Tadjer, A., Villemin, D., Najdoska-Bogdanov, M., Bogdanov, J., & Cherqaoui, D. (2019). QSAR and molecular docking studies of indole-based analogs as HIV-1 attachment inhibitors. Journal of Molecular Structure, 1193, 429–443. https://doi.org/https://doi.org/10.1016/j.molstruc.2019.05.056
- Kanwal, F., Kramer, J., Asch, S. M., Chayanupatkul, M., Cao, Y., & El-Serag, H. B. (2017). Risk of Hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology, 153(4), 996–1005.e1. https://doi.org/https://doi.org/10.1053/j.gastro.2017.06.012
- Küçükgüzel, G., & Çikla-Süzgün, P. (2015). Recent advances bioactive 1,2,4-triazole-3-thiones. European Journal of Medicinal Chemistry, 97, 830–870. https://doi.org/https://doi.org/10.1016/j.ejmech.2014.11.033
- LigandScout, V. 4.3; Inte:Ligand GmbH, Clemesn-Maria-Hofbaurer-G. (2344). 6, Maria Enzersdorf, Austria. (n.d.). http://www.inteligand.com. http://www.inteligand.com
- Lin, K., Perni, R. B., Kwong, A. D., & Lin, C. (2006). VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells. Antimicrobial Agents and Chemotherapy, 50(5), 1813–1822. https://doi.org/https://doi.org/10.1128/AAC.50.5.1813-1822.2006
- Lundin, M., Monne, M., Widell, A., von Heijne, G., & Persson, M. A. A. (2003). Topology of the membrane-associated hepatitis C virus protein NS4B. Journal of Virology, 77(9), 5428–5438. https://doi.org/https://doi.org/10.1128/JVI.77.9.5428-5438.2003
- Manfroni, G., & Cannalire, R. (2019). Evolution of HCV NS4B inhibitors. In Sofia M. (Eds.), HCV: The Journey from Discovery to a Cure. Topics in Medicinal Chemistry (Vol. 32). Cham: Springer. https://doi.org/https://doi.org/10.1007/7355_2018_46
- Manvar, P., Shaikh, F., Kakadiya, R., Mehariya, K., Khunt, R., Pandey, B., & Shah, A. (2016). Synthesis of novel imidazo[1,2-a]pyridine-4-hydroxy-2H-coumarins by Groebke-Blackburn-Bienaymé multicomponent reaction as potential NS5B inhibitors. Tetrahedron, 72(10), 1293–1300. https://doi.org/https://doi.org/10.1016/j.tet.2016.01.023
- Mishra, S., Pandey, A., & Manvati, S. (2020). Coumarin: An emerging antiviral agent. Heliyon, 6(1), e03217. https://doi.org/https://doi.org/10.1016/j.heliyon.2020.e03217
- Naud, J., Lemke, C., Goudreau, N., Beaulieu, E., White, P. D., Llinàs-Brunet, M., & Forgione, P. (2008). Potent triazolyl-proline-based inhibitors of HCV NS3 protease. Bioorganic & Medicinal Chemistry Letters, 18(11), 3400–3404. https://doi.org/https://doi.org/10.1016/j.bmcl.2008.04.012
- Pelosi, L. A., Voss, S., Liu, M., Gao, M., & Lemm, J. A. (2012). Effect on Hepatitis C Virus Replication of Combinations of Direct-Acting Antivirals, Including NS5A Inhibitor Daclatasvir. Antimicrobial Agents and Chemotherapy, 56(10), 5230–5239. https://doi.org/https://doi.org/10.1128/AAC.01209-12
- Pinto, V., Araújo, J., Silva, R., da Costa, G., Cruz, J., De A. Neto, M., Campos, J., Santos, C., Leite, F., & Junior, M. (2019). In silico study to identify new antituberculosis molecules from natural sources by hierarchical virtual screening and molecular dynamics simulations. Pharmaceuticals, 12(1), 36. https://doi.org/https://doi.org/10.3390/ph12010036
- Podlogar, B. L., Muegge, I., & Brice, L. J. (2001a). Computational methods to estimate drug development parameters. Current Opinion in Drug Discovery & Development, 4(1), 102–109. https://doi.org/https://doi.org/10.1124/pr.112.007336
- Rai, R., & Deval, J. (2011). New opportunities in anti-hepatitis C virus drug discovery: Targeting NS4B. Antiviral Research, 90(2), 93–101. https://doi.org/https://doi.org/10.1016/j.antiviral.2011.01.009
- Ramos, R. S., Macêdo, W. J. C., Costa, J. S., da Silva, C. H. T. d P., Rosa, J. M. C., da Cruz, J. N., de Oliveira, M. S., de Aguiar Andrade, E. H., e Silva, R. B. L., Souto, R. N. P., & Santos, C. B. R. (2020). Potential inhibitors of the enzyme acetylcholinesterase and juvenile hormone with insecticidal activity: Study of the binding mode via docking and molecular dynamics simulations. Journal of Biomolecular Structure & Dynamics, 38(16), 4687–4623. https://doi.org/https://doi.org/10.1080/07391102.2019.1688192
- Santos, K. L. B. d., Cruz, J. N., Silva, L. B., Ramos, R. S., Neto, M. F. A., Lobato, C. C., Ota, S. S. B., Leite, F. H. A., Borges, R. S., Silva, C. H. T. P. d., Campos, J. M., & Santos, C. B. R. (2020). Identification of novel chemical entities for adenosine receptor type 2A using molecular modeling approaches. Molecules, 25(5), 1245. https://doi.org/https://doi.org/10.3390/molecules25051245
- Santos, C. B. R., Santos, K. L. B., Cruz, J. N., Leite, F. H. A., Borges, R. S., Taft, C. A., … Silva, C. H. T. P. (2020). Molecular modeling approaches of selective adenosine receptor type 2A agonists as potential anti-inflammatory drugs. Journal of Biomolecular Structure and Dynamics, https://doi.org/https://doi.org/10.1080/07391102.2020.1761878
- Schüürmann, G., Ebert, R.-U., Chen, J., Wang, B., & Kühne, R. (2008). External validation and prediction employing the predictive squared correlation coefficient test set activity mean vs. training set activity mean. Journal of Chemical Information and Modeling, 48(11), 2140–2145. https://doi.org/https://doi.org/10.1021/ci800253u
- Shi, L. M., Fang, H., Tong, W., Wu, J., Perkins, R., Blair, R. M., Branham, W. S., Dial, S. L., Moland, C. L., & Sheehan, D. M. (2001). QSAR Models using a large diverse set of estrogens. Journal of Chemical Information and Computer Sciences, 41(1), 186–195. https://doi.org/https://doi.org/10.1021/ci000066d
- Talete srl. (n.d.). Dragon (Software for Molecular Descriptor Calculation, version 7.0). Retrieved from https://chm.kode-solutions.net/products_dragon.php
- Tao, X., Wang, N., Wang, J., Fu, Z., Gu, Z., Zhang, Y., Chen, S., Wang, L., & Yu, L. (2019). Preclinical evaluation of Amphihevir, a first-in-class clinical Hepatitis C virus NS4B inhibitor. Antimicrobial Agents and Chemotherapy, 63(12), e01237-19. https://doi.org/https://doi.org/10.1128/AAC.01237-19
- Tian, S., Wang, J., Li, Y., Li, D., Xu, L., & Hou, T. (2015). The application of in silico drug-likeness predictions in pharmaceutical research. Advanced Drug Delivery Reviews. Elsevier, 86, 2–10. https://doi.org/https://doi.org/10.1016/j.addr.2015.01.009
- Todeschini, R., & Consonni, V. (2000). Handbook of molecular descriptors (Vol. 11). Wiley-VCH. https://doi.org/https://doi.org/10.1002/9783527613106
- Todeschini, R., & Consonni, V. (2009). Molecular descriptors for chemoinformatics. Wiley-VCH.
- Tropsha, A., Gramatica, P., & Gombar, V. (2003). The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSPR models. QSAR & Combinatorial Science, 22(1), 69–77. https://doi.org/https://doi.org/10.1002/qsar.200390007
- Walker, M. A. (1999). Hepatitis C virus: An overview of current approaches and progress. Drug Discovery Today, 4(11), 518–529. https://doi.org/https://doi.org/10.1016/S1359-6446(99)01414-2
- Wang, Z., Chen, Z., Li, J., Huang, J., Zheng, C., & Liu, J. P. (2020). Combined 3D-QSAR, molecular docking and molecular dynamics study on the benzimidazole inhibitors targeting HCV NS5B polymerase. Journal of Biomolecular Structure & Dynamics, 38(4), 1071–1082. https://doi.org/https://doi.org/10.1080/07391102.2019.1593244
- Yu, G.-Y., Lee, K.-J., Gao, L., & Lai, M. M. C. (2006). Palmitoylation and polymerization of hepatitis C virus NS4B protein. Journal of Virology, 80(12), 6013–6023. https://doi.org/https://doi.org/10.1128/JVI.00053-06
- Zając, M., Muszalska, I., Sobczak, A., Dadej, A., Tomczak, S., & Jelińska, A. (2019). Hepatitis C – new drugs and treatment prospects. European Journal of Medicinal Chemistry, 165, 225–249. https://doi.org/https://doi.org/10.1016/j.ejmech.2019.01.025
- Zeuzem, S., Andreone, P., Pol, S., Lawitz, E., Diago, M., Roberts, S., Focaccia, R., Younossi, Z., Foster, G. R., Horban, A., Ferenci, P., Nevens, F., Müllhaupt, B., Pockros, P., Terg, R., Shouval, D., van Hoek, B., Weiland, O., Van Heeswijk, R., … Beumont, M. (2011). Telaprevir for retreatment of HCV infection. New England Journal of Medicine, 364(25), 2417–2428. https://doi.org/https://doi.org/10.1056/NEJMoa1013086
- Zhang, X., Zhang, N., Chen, G., Turpoff, A., Ren, H., Takasugi, J., Morrill, C., Zhu, J., Li, C., Lennox, W., Paget, S., Liu, Y., Almstead, N., Njoroge, F. G., Gu, Z., Komatsu, T., Clausen, V., Espiritu, C., Graci, J., … Karp, G. M. (2013). Discovery of novel HCV inhibitors: Synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B. Bioorganic & Medicinal Chemistry Letters, 23(13), 3947–3953. https://doi.org/https://doi.org/10.1016/j.bmcl.2013.04.049
- Zhang, N., Zhang, X., Zhu, J., Turpoff, A., Chen, G., Morrill, C., Huang, S., Lennox, W., Kakarla, R., Liu, R., Li, C., Ren, H., Almstead, N., Venkatraman, S., Njoroge, F. G., Gu, Z., Clausen, V., Graci, J., Jung, S. P., … Karp, G. M. (2014). Structure-activity relationship (SAR) optimization of 6-(indol-2-yl)pyridine-3-sulfonamides: Identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4B . Journal of Medicinal Chemistry, 57(5), 2121–2135. https://doi.org/https://doi.org/10.1021/jm401621g